
We are solving the $200 billion epidemic of falsified medicine.
Validproof is a pharmaceutical traceability software business that helps drug manufacturers and supply chain partners meet traceability obligations with verifiable product evidence. It grew from the insight that fragmented tracking and static identifiers leave gaps that falsified medicines exploit, so it built a track-and-trace platform that records a continuous, immutable history for each medicine unit.
The platform centers on proof of origin, authenticity, delivery, and decommissioning, giving each unit a unique digital identity that logs ownership changes and movement from manufacture to dispensing. It displaces batch-record snapshots and siloed ledgers with end-to-end visibility and audit-ready records, serving pharmaceutical stakeholders responsible for compliance and product integrity.

Remedial Health
remedial.health

Veripad
veripad.co
HeartNet
Verimed

RxAll
rxall.net
TraceRx

BlueTrace
blue-trace.com

PharmaSecure
pharmasecure.com

Theora
theorahq.com

Everledger
everledger.io

121nexus
121nexus.com

Chainparency
chainparency.com

InfiniTrak
infinitrak.us

Truentity
truentity.com

Chronicled
chronicled.com

H+Trace
h-trace.com

Verifiable
verifiable.com

Unravel Health
unravel.health

PharmID
pharmid.com

SourceSentinel
sourcesentinel.com
Companies similar to ValidProof include Remedial Health, Veripad, HeartNet and Verimed.
ValidProof was founded in 2023.
ValidProof's headquarters is located in Helsinki, FI.
ValidProof's most recent funding round was for $20k (USD) in March 2023.
As of Mar 13, 2023, ValidProof has disclosed funding of $20k · USD coverage: 1/1 eligible rounds converted · 0 undisclosed amounts · 0 missing FX rates (USD). Undisclosed round amounts are excluded.